Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Latest https://ift.tt/HAad5FK

No comments:

Post a Comment

"Release Them": Relatives Of Gaza Hostages Break Into Israeli Parliament Panel

A group of relatives of Israelis held hostage by Palestinian gunmen in Gaza rushed into a parliamentary committee session in Jerusalem on Mo...